中國生物製藥(01177)首三季度盈利增長134.9% X
30/10/2024 23:38
<匯港通訊>           中國生物製藥(01177)公布,今年首三季度歸屬於母公司持有者盈利(未經審計)約41.7億元人民幣,較去年同期增長約134.9%。(WH)



Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.